A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver.
Prednisone was granted FDA approval on 21 February 1955.
Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.
Tennessee Oncology, Nashville, Tennessee, United States
Florida Cancer Specialists, Fort Myers, Florida, United States
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, United States
Cancer Institute at Oregon Health and Science University, Portland, Oregon, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Medisch Centrum Alkmaar, Alkmaar, Noord-Holland, Netherlands
Hôpital Henri Mondor, Créteil, France
Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite cedex, France
Centre Henri Becquerel, Rouen, France
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Novartis, Basel, Switzerland
University of Cologne, Cologne, NRW, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.